Researchers believe that a re-classification of NAFLD, which affects nearly a billion people globally with no drug treatment currently on the market, is essential to improve patient understanding and industry funding to better mitigate its impact.
Primary sclerosing cholangitis (PSC) is a chronic, progressive disease of the gallbladder and liver characterized by inflammation and scarring of the bile ducts.